Microplate Blowdown Evaporator for LC/MS Porvair
The Ultravap Levante is a new introduction to Porvair Sciences’ popular series of nitrogen blowdown sample concentrators and evaporators.
With the needs of LC/MS users very much in mind, the Ultravap Levante offers rapid programmable dry down of samples dissolved in common chromatography solvents such as acetonitrile, dichloromethane and methanol. With 10 stored programs and a full colour screen the Ultravap Levante is both easy to use and highly productive. The plate stage can be programmed to rise as evaporation proceeds, ensuring faster dry down. Both gas temperature and flow rate can be programmed for each stage of a dry-down method and stored in instrument memory. RS232 connection allows the Ultravap Levante to be controlled from a computer or liquid handling robot in addition to the integral touchscreen. A choice of spiral or straight blow-down needles enables the fastest results to be achieved with every type of microplate.
Porvair have re-designed the classic single plate blowdown evaporator to meet the needs of the modern laboratory. The Ultravap Levante now makes it even easier to integrate an automatic dry down step into your biological sample preparation protocol.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance